Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Metastatic Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

    Contact: Study coordinator (Kun Wang, PhD)
    Contact: Principal Investigator (Kun Wang, PhD)
  • Public Health Institute of Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Li Ling, PhD)
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Herui Yao, PhD) · yaoherui@mail.sysu.edu.cn · +86 13500018020
    Contact: Principal Investigator (Herui Yao, PhD)
  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Shusen Wang, PhD)
    Contact: Principal Investigator (Shusen Wang, PhD)
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

    Contact: Study coordinator (Mei Huang, MD)
  • The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Ying Lin, PhD)
  • Shantou Central Hospital, Shantou, Guangdong, China

    Contact: Study coordinator (Zhiyong Wu, MD)
  • Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, Guangdong, China

    Contact: Study coordinator (Caiwen Du, PhD)
  • Shenzhen People's Hospital, Shenzhen, Guangdong, China

    Contact: Study coordinator (Ruilian Xu, Master)
  • Affiliated Hospital of Guangdong Medical University, Zhangjiang, Guangdong, China

    Contact: Study coordinator (Ying Zhang, MD)
  • Fifth Subsidiary Sun Yat-sen University Hospital, Zhuhai, Guangdong, China

    Contact: Study coordinator (Peijian Peng, PhD)
  • Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Contact: Study coordinator (Yongkui Lu, MD)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Quchang Ouyang, PhD)
מובילי המחקר
  • Herui Yao, PhD

    Study Chair

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  • Shusen Wang, PhD

    Principal Investigator

    Sun Yat-sen University

  • Kun Wang, PhD

    Principal Investigator

    Guangdong Provincial People's Hospital

  • Peijian Peng, PhD

    Principal Investigator

    Fifth Subsidiary Sun Yat-sen University Hospital

  • Li Ling, PhD

    Principal Investigator

    Public Health Institute of Sun Yat-sen University

  • Yongkui Lu, MD

    Principal Investigator

    Affiliated Cancer Hospital of Guangxi Medical University

  • Quchang Ouyang, PhD

    Principal Investigator

    Hunan Cancer Hospital

  • Ying Lin, phD

    Principal Investigator

    First Affiliated Hospital, Sun Yat-Sen University

  • Ying Zhang, MD

    Principal Investigator

    Affiliated Hospital of Guangdong Medical University

  • Mei Huang, MD

    Principal Investigator

    The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

  • Zhiyong Wu, MD

    Principal Investigator

    Shantou Central Hospitalv

  • Cai'wen Du, PhD

    Principal Investigator

    Chinese Academy of Medical Sciences